IL101455A0 - Pharmaceutical compositions containing a methylthioribose kinase inhibitor - Google Patents

Pharmaceutical compositions containing a methylthioribose kinase inhibitor

Info

Publication number
IL101455A0
IL101455A0 IL101455A IL10145592A IL101455A0 IL 101455 A0 IL101455 A0 IL 101455A0 IL 101455 A IL101455 A IL 101455A IL 10145592 A IL10145592 A IL 10145592A IL 101455 A0 IL101455 A0 IL 101455A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
kinase inhibitor
methylthioribose kinase
methylthioribose
Prior art date
Application number
IL101455A
Original Assignee
State Of Oregon On Behalf Of T
Univ Oregon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by State Of Oregon On Behalf Of T, Univ Oregon filed Critical State Of Oregon On Behalf Of T
Publication of IL101455A0 publication Critical patent/IL101455A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL101455A 1991-04-18 1992-04-02 Pharmaceutical compositions containing a methylthioribose kinase inhibitor IL101455A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919108348A GB9108348D0 (en) 1991-04-18 1991-04-18 Medicaments

Publications (1)

Publication Number Publication Date
IL101455A0 true IL101455A0 (en) 1992-12-30

Family

ID=10693536

Family Applications (1)

Application Number Title Priority Date Filing Date
IL101455A IL101455A0 (en) 1991-04-18 1992-04-02 Pharmaceutical compositions containing a methylthioribose kinase inhibitor

Country Status (4)

Country Link
GB (1) GB9108348D0 (en)
IL (1) IL101455A0 (en)
MX (1) MX9201791A (en)
WO (1) WO1992018118A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180714A (en) * 1990-10-31 1993-01-19 Health Research, Inc. Adenosine compounds for the treatment of diseases caused by parasitic protozoa
US20110138888A1 (en) * 2008-07-21 2011-06-16 Amany Elshorbagy Treatment of obesity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820692A (en) * 1986-01-30 1989-04-11 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And Oregon State University Methylthioribose analogs, their preparation and use as medicinal agents and biocides

Also Published As

Publication number Publication date
GB9108348D0 (en) 1991-06-05
WO1992018118A1 (en) 1992-10-29
MX9201791A (en) 1992-10-01

Similar Documents

Publication Publication Date Title
HU9303143D0 (en) Pharmaceutical compositions
ZA922834B (en) Pharmaceutical compositions
NZ244766A (en) Bi-aromatic compounds and pharmaceutical compositions
AP9200356A0 (en) Pharmaceutical composition
GB2269382B (en) Pharmaceutical compounds
IL102372A0 (en) Pharmaceutical composition containing a non-n-methyl-d-aspartate antagonist
GB2251617B (en) Pharmaceutical compositions containing substituted 3-hydroxypyridin-4-ones
IL99867A0 (en) Pharmaceutical compositions containing activin a
GB9214757D0 (en) Pharmaceutical compositions
IL101455A0 (en) Pharmaceutical compositions containing a methylthioribose kinase inhibitor
IL101625A0 (en) Pharmaceutical compound
GB9120672D0 (en) Pharmaceutical compositions
IL101624A0 (en) Pharmaceutical compound
GB9221212D0 (en) Pharmaceutical compositions
IL101998A0 (en) 6-o-alkylelsamicin a derivatives and pharmaceutical compositions containing them
GB9200414D0 (en) Pharmaceutical compositions
GB9121989D0 (en) Pharmaceutical compositions
GB9110884D0 (en) Pharmaceutical compositions
GB9123423D0 (en) Pharmaceutical compositions
GB9113805D0 (en) Pharmaceutical compositions
GB9118481D0 (en) Pharmaceutical compositions
GB9113621D0 (en) Pharmaceutical compositions
GB9107278D0 (en) Pharmaceutical compositions
GB9119048D0 (en) Pharmaceutical compositions
GB9118128D0 (en) Pharmaceutical compositions